Unique ID issued by UMIN | UMIN000000791 |
---|---|
Receipt number | R000000950 |
Scientific Title | The Multicentre pilot study of the effet of pravastatin treatment on high molecular weight adiponectin blood concentration in patients with dyslipidemia -Kanazawa, Yokohama- |
Date of disclosure of the study information | 2007/08/08 |
Last modified on | 2011/08/08 09:17:05 |
The Multicentre pilot study of the effet of pravastatin treatment on high molecular weight adiponectin blood concentration in patients with dyslipidemia
-Kanazawa, Yokohama-
Dyslipidemia Open labeled pilot study by lipid lowering therapy with Pravastatin to elucidate the effect to increase High-molecular weight adiponectin by investigators in Nippon Yokohama(DOLPHIN)
The Multicentre pilot study of the effet of pravastatin treatment on high molecular weight adiponectin blood concentration in patients with dyslipidemia
-Kanazawa, Yokohama-
Dyslipidemia Open labeled pilot study by lipid lowering therapy with Pravastatin to elucidate the effect to increase High-molecular weight adiponectin by investigators in Nippon Yokohama(DOLPHIN)
Japan |
Dyslipidemia
Medicine in general | Endocrinology and Metabolism |
Others
NO
The purpose of this study is to investigate pravastatin treatment is effective for increasing serum high-molecular weight adiponectin concentration in dyslipidemia patients.
Efficacy
The change of serum high-molecular weight adiponectin concentration
1.The alteration in glucose metabolism
2.The change in serum lipid levels
3.The change in serum hs-CRP
4.The change in serum total adiponectin concentration
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Patients will receive pravastatin 5-10mg/day for 6 months.
20 | years-old | <= |
Not applicable |
Male and Female
1. Patients diagnosed as dyslipidemia(LDL-C>140mg/dL)
2. Outpatient clinic patients in Kanazawa ward
3. Patients who fall into category 2 or 3 of Japan Atherosclerosis Society(JAS) Guidelines for diagnosis and prevention of atherosclerotic cardiovascular disease for Japanese
4. Informed concent on the form filled out by the patient.
1. Familial hyperlipidemia
2. Ischemic heart disease
3. Patients who is already taking statin
80
1st name | |
Middle name | |
Last name | Uru Nezu |
Yokohama City University Graduate School of Medicine
Department of Endocrinology & Metabolism
3-9 Fukuura, Kanazawa-ward, Yokohama 236-0004
045-787-2639
1st name | |
Middle name | |
Last name | Uru Nezu |
Yokohama City University Graduate School of Medicine
Department of Endocrinology & Metabolism
3-9 Fukuura, Kanazawa-ward, Yokohama 236-0004
045-787-2639
Yokohama City University Graduate School of Medicine
Department of Endocrinology & Metabolism
Yokohama City University Graduate School of Medicine
Department of Endocrinology & Metabolism
Self funding
NO
2007 | Year | 08 | Month | 08 | Day |
Unpublished
Completed
2007 | Year | 01 | Month | 26 | Day |
2007 | Year | 04 | Month | 01 | Day |
2009 | Year | 03 | Month | 01 | Day |
2009 | Year | 03 | Month | 01 | Day |
2009 | Year | 04 | Month | 01 | Day |
2009 | Year | 05 | Month | 01 | Day |
2007 | Year | 08 | Month | 07 | Day |
2011 | Year | 08 | Month | 08 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000950
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |